Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2008
11/12/2008EP1511732B9 Process for the manufacture of quinoline derivatives
11/12/2008EP1478659B1 Biologically active peptides
11/12/2008EP1436321B9 Synthesis of cyclosporin analogs
11/12/2008EP1404811B1 Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis
11/12/2008EP1315490B1 A method for treating allergies using substituted pyrazoles
11/12/2008EP1261607B1 2,4-disubstituted thiazolyl derivatives
11/12/2008EP1259615B1 Antibodies against eotaxin and their use
11/12/2008EP1231935B1 Attenuation of angiogenesis by use of chondroitin sulfate degrading enzymes
11/12/2008EP1204421B1 Stress protein-peptide complexes as vaccines against intra-cellular pathogens
11/12/2008EP1064551B1 Development of human monoclonal antibodies and uses thereof
11/12/2008EP0750668B1 Novel muteins of ifn-beta
11/12/2008EP0701569B1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
11/12/2008CN101305021A Compositions and methods for diagnosing and treating an inflammation
11/12/2008CN101304995A Thiazole derivatives and use thereof
11/12/2008CN101304765A Conjugation of streptococcal capsular saccharides
11/12/2008CN101304761A Treatment with an oncolytic virus and an immunostimulant for in vivo enhancement of immune system recognition of neoplasms
11/12/2008CN101302515A Human antibodies that bind human TNF(alpha)
11/12/2008CN101302491A Highly effective method for amplifying activated lymphocyte and cultivation system
11/12/2008CN101302469A Fleece-flower root wine
11/12/2008CN101302468A Black-bone chicken sticky rice sweet wine and preparation thereof
11/12/2008CN101302467A Tuckahoe wine
11/12/2008CN101302252A Extrasin alphal (Tal) analogue, production process and medical use thereof
11/12/2008CN101302251A Cyanea-originated glucoprotein having immunopotentiation activity, preparation and use thereof
11/12/2008CN101302204A Quinazolone compound, composition and application including the same
11/12/2008CN101302182A Virus polymerase inhibitors
11/12/2008CN101301465A Fowl transfer factor nano liposomes and preparation thereof
11/12/2008CN101301462A Decoction for treating cold urticaria
11/12/2008CN101301461A Medicament for treating urticaria
11/12/2008CN101301459A Medicated pillow
11/12/2008CN101301427A Medicament composition and preparation and application thereof
11/12/2008CN101301413A Cordyceps sinensis and Rhodiola rosea capsules and preparation thereof
11/12/2008CN101301392A Chinese medicine for treating systemic lupus erythematosus and preparation thereof
11/12/2008CN101301362A Externally used medicament composition for treating allergic asthma
11/12/2008CN101301346A Composition for improving organism immunity of aquatic livestock
11/12/2008CN101301344A Oral Chinese medicine for treating blood-heat drug induced dermatitis
11/12/2008CN101301341A Decoction for treating acute eczema
11/12/2008CN101301330A Codonopsis pilosula pollen capsules and preparation thereof
11/12/2008CN101301319A Preparation of granada flower polyphenol and uses thereof
11/12/2008CN101301316A Compound formulation containing lactobacillus leavening and preparation and use thereof
11/12/2008CN101301295A Use of compound pachymic acid for preparing medicament
11/12/2008CN101301075A Functional food product for strengthening immunity containing leek seeds and preparation thereof
11/12/2008CN100432093C High-purity composition comprising (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one and a process for purifying (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
11/12/2008CN100432062C Terphenyl derivatives, preparation thereof, compositions containing same
11/12/2008CN100432055C Tricyclic protein kinase inhibitors
11/12/2008CN100432049C Cycloalkene derivatives, process for producing the same and use
11/12/2008CN100431600C Pharmaceutical compositions
11/12/2008CN100431582C Extraction process of aloe gel concentrate
11/12/2008CN100431571C Oral Chinese medicine preparation for replenishing vitamins and trace elements
11/11/2008US7449581 6-Substituted pyrido-pyrimidines
11/11/2008US7449576 potent antagonists of the CCR1 receptor; inflammation; (5-Chloro-2-piperazin-1-yl-phenyl)-phenyl-methanone
11/11/2008US7449575 preparing 4-[[4-amino-6-[(2,6-dichlorophenyl)methyl]-1,3,5-triazin-2-yl]amino]benzonitrile by reacting 2,6-dichlorobenzeneethanimidamide with phenyl N'-cyano-N-(4-cyanophenyl)-carbamimidate in a reaction-inert solvent; HIV (Human Immunodeficiency Virus) infection
11/11/2008US7449557 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
11/11/2008US7449493 N-[2-[[1-[[[(2,4-dimethylphenyl)methyl]amino]methyl]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide; monocyte chemoattractant proteins receptor antagonists or partial agonists/antagonists; antiinflammatory agent, autoimmune diseases; rheumatoid arthritis, multiple sclerosis, atherosclerosis
11/11/2008US7449492 Therapeutic agents—I
11/11/2008US7449479 Hepatitis C virus inhibitors
11/11/2008US7449472 Methods of inhibiting p38 with substituted bicyclic pyrimidines
11/11/2008US7449466 Cyclic aminophenyl sulfamate derivative
11/11/2008US7449450 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
11/11/2008US7449446 Synergistic mixture; anticoagulants
11/11/2008US7449324 Determining in a sample of an animal the presence of a viral component by reacting the sample with a nucleic acid or an antibody reactive with component of an avian pneumovirus, and crossreactive with a component of MPV (metapneumovirus)
11/11/2008US7449201 Storage stable power compositions of interleukin-4 receptor
11/11/2008US7449177 administering to gamma-interferon, in combination with antihistamines, antiallergens, corticosteroids or mixtures, for the treatment of autoimmune skin diseases; suppression of chemotaxis and function of eosinophils
11/11/2008US7449175 Delivery of erectile dysfunction drugs through an inhalation route
11/11/2008US7449174 Delivery of analgesics through an inhalation route
11/11/2008US7449172 Delivery of antiemetics through an inhalation route
11/06/2008WO2008134513A2 Copper lowering treatment of autoimmune diseases
11/06/2008WO2008133857A1 Anti-mdl-1 antibodies
11/06/2008WO2008133684A1 Antibodies that bind both il-17a and il-17f and methods of using the same
11/06/2008WO2008133595A1 Compositions and methods for stimulating an immune response in-vivo and in-vitro
11/06/2008WO2008133192A1 Fused imidazole compound and use thereof
11/06/2008WO2008133155A1 Bicyclic heterocyclic compound
11/06/2008WO2008132709A1 Products for altering il-33 activity and methods therefor
11/06/2008WO2008132152A1 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90
11/06/2008WO2008132134A1 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90
11/06/2008WO2008131599A1 T-cell receptor vaccines materials and methods
11/06/2008WO2008131547A1 'triazine derivatives, compositions containing such derivatives, and methods of treatment of cancer and autoimmune diseases using such derivatives'
11/06/2008WO2008116149A3 Apoptotic anti- ige antibodies binding the membrane-bound ige
11/06/2008WO2008113881B1 Compound that is a dual inhibitor of enzymes pde7 and/or pde4, pharmaceutical compositions and uses thereof
11/06/2008WO2008091682A3 Soluble fc gamma r1a for reducing inflammation
11/06/2008WO2008083228A3 Compositions and methods for treating inflammation and auto-immune diseases
11/06/2008WO2008033432A3 Immune modulation by chemically modified ribonucleosides and oligoribonucleotides
11/06/2008WO2008009476A3 Concentrated methotrexate solutions
11/06/2008WO2007126727A8 WATER SOLUBLE β-GLUCAN, GLUCOSAMINE, AND N-ACETYLGLUCOSAMINE COMPOSITIONS AND METHODS FOR MAKING THE SAME
11/06/2008WO2007101063A3 Treatment of development-related disorders
11/06/2008US20080275376 Method for enhancing immune responses in mammals
11/06/2008US20080275123 N-halogenated amino acid formulations
11/06/2008US20080275122 For contact lenses; surface treatment; respiratory disorders
11/06/2008US20080275102 And 3-oximidoindole derivatives; cannabinoid receptor antagonists; cardiovascular, gastrointestinal, autoimmune, and neurodegenerative disorders; obesity, infections; antidiabetic and antiallergen agents; acylation, oximination
11/06/2008US20080275099 Solid Forms of (E)-1-(4-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone Oxime
11/06/2008US20080275077 Pharmaceutical formulations comprising an immune response modifier
11/06/2008US20080275076 exhibit an acceptable bioavailability of sirolimus together with excipient, when administered to a mammal releases sirolimus in a controlled manner and reduces inter- and/or intra-individual variations compared to those of Rapamune (sirolimus) administered under the same condition; side effect reduction
11/06/2008US20080275063 C-{4-[6-(2-Ethoxy-phenyl)-pyrimidin-4-ylamino]-phenyl}-N-propyl-methanesulfonamide; antiinflammatories, antiproliferatives, analgesics; cardiovascular disorders, neurodegenerative diseases; immunotherapy
11/06/2008US20080275053 Heterocyclyl Compounds
11/06/2008US20080275039 Geldanamycin Derivatives and the Method for Biosynthesis Thereof
11/06/2008US20080275038 Imidazopyridine Derivatives as A2b Adenosine Receptor Antagonists
11/06/2008US20080275031 Inhibitors of C-FMS Kinase
11/06/2008US20080275028 Modulators or Alpha7 Nicotinic Acetylcholine Receptors and Therapeutic Uses Thereof
11/06/2008US20080275027 Piperazinone Derivatives Useful as Histamine H3 Receptor Antagonists and/or Inverse Agonists
11/06/2008US20080275008 Modulate sphingosine-1-phosphate (S1P) receptors with fewer side effects; for example, 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentylphosphonic acid monoester; prophylactic or therapeutic agents against rejection of organ transplants, skin grafts, rheumatoid arthritis, lupus
11/06/2008US20080274998 Adjust biological activity of moesin by binding; parasiticides; bactericides; central nervous system disorders; Down's syndrome; antiinflamamtory agents; anticancer agents; autoimmune diseases; skin disorders; gastrointestinal disorders
1 ... 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 ... 1172